October 27, 2014 / 11:24 AM / 4 years ago

Valeant says ready to raise Allergan bid to at least $200/share

Oct 27 (Reuters) - Valeant Pharmaceuticals International Inc said it is prepared to improve its offer for Allergan Inc to at least $200 per share.

The Botox maker’s shares closed at $184.21 on Friday.

Valeant Chief Executive Michael Pearson said in a letter to Allergan’s board that Allergan’s stock would not be trading at the multiples it is now if it were not for Valeant’s offer.

Pearson told Reuters last week that a possible revised stock-and-cash bid would be worth more than $200 per share, assuming that Valeant’s stock rises, and would include more cash.

Reporting by Sayantani Ghosh in Bangalore; Editing by Sriraj Kalluvila

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below